This document is an excerpt from the EUR-Lex website
Document 32004R1101R(01)
Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (OJ L 211, 12.6.2004)
Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (OJ L 211, 12.6.2004)
Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (OJ L 211, 12.6.2004)
OJ L 337, 13.11.2004, p. 73–73
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
ELI: http://data.europa.eu/eli/reg/2004/1101/corrigendum/2004-11-13/oj
|
13.11.2004 |
EN |
Official Journal of the European Union |
L 337/73 |
Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin
( Official Journal of the European Union L 211 of 12 June 2004 )
In the Annex, on page 5, point A is replaced as follows:
‘A. The following substance(s) is(are) inserted in Annex I (List of pharmacologically active substances for which maximum residue limits have been fixed).
1. Anti-infectious agents
1.2. Antibiotics
1.2.4. Macrolides
|
Pharmacologically active substance(s) |
Marker residue |
Animal species |
MRLs |
Target tissues |
|
“Tulathromycin |
(2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopy-ranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents |
Bovine (1) |
100 μg/kg |
Fat |
|
3 000 μg/kg |
Liver |
|||
|
3 000 μg/kg |
Kidney |
|||
|
Porcine |
100 μg/kg |
Skin + fat |
||
|
3 000 μg/kg |
Liver |
|||
|
3 000 μg/kg |
Kidney” ’ |
(1) Not for use in animals from which milk is produced for human consumption.